From the CEO of Proscia: Best in KLAS and Why It Matters
recent articles
Diaceutics to host 'Precision Medicine in Solid Tumors' virtual event on July 18, 2023, spotlighting the latest advancements and discussing the future of personalized cancer treatment. BELFAST, NORTHERN IRELAND (PRWEB) JULY 14, 2023...
Toronto, Canada, May 19, 2023 — Diagnexia Canada Limited, owned by Deciphex Limited and internationally recognized as a leading provider of pathology services, is delighted to announce the launch of its cutting-edge accessioning facility in...
From the Proscia blog: Ensuring the quality of slides in digital pathology is a meticulous and time-consuming process. The individuals responsible for quality control can vary greatly, ranging from specially trained technicians conducting...
Paige platform to be adopted by University of Florida College of Medicine - Jacksonville to improve cancer diagnoses NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical artificial...
ETH Zurich and Roche are joining forces in Basel to advance the development of new methods that facilitate the search for medicines. Together, they will train specialists for the biomedical challenges of our time. ETH Zurich and Roche...
Indica Labs just released their latest white paper on HALO AI that discusses networks for tissue classification, nuclear segmentation, nuclear phenotyping, as well as new functionality for AI-based membrane segmentation in...
